Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06541990 · ClinicalTrials.gov registry record · NA

Psychoeducational Intervention for Patients With Hepatocellular Carcinoma

A NA study of Hepatocellular Carcinoma, sponsored by Massachusetts General Hospital.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT06541990 is a NA study of Hepatocellular Carcinoma that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 50 participants, below the 257-participant average among 145 other Hepatocellular Carcinoma trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06541990, a NA study of Hepatocellular Carcinoma, is actively recruiting participants, sponsored by Massachusetts General Hospital.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

This study aims to refine and pilot test HARMONY, a psychoeducational intervention for patients with newly diagnosed hepatocellular carcinoma (HCC).

Conditions Studied

Interventions

  • OTHER Enhanced usual care
  • BEHAVIORAL HARMONY

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2024-10-28
Est. Completion 2026-09-30
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT06541990

The ClinicalTrials.gov registry entry for NCT06541990 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 257-participant average among 145 other Hepatocellular Carcinoma trials with a reported enrollment target (81% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hepatocellular Carcinoma appearing as the primary indexed condition, and to 2 interventions - of which Enhanced usual care is the first listed.

NCT06541990 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06541990 about?

NCT06541990 is a clinical study titled "Psychoeducational Intervention for Patients With Hepatocellular Carcinoma". This study aims to refine and pilot test HARMONY, a psychoeducational intervention for patients with newly diagnosed hepatocellular carcinoma (HCC).

What is the current status of trial NCT06541990?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2024-10-28. Estimated completion is 2026-09-30.

What conditions does trial NCT06541990 study?

This clinical trial studies the following conditions: Hepatocellular Carcinoma.

What interventions are being tested in trial NCT06541990?

The interventions under investigation include: Enhanced usual care (OTHER), HARMONY (BEHAVIORAL).

Who is sponsoring clinical trial NCT06541990?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06541990 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hepatocellular Carcinoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.